Balkan Masterclass in Clinical Oncology
30 ESCO credits
11.05.2011 - 15.05.2011
Dubrovnik
MASTERCLASS
Description
Chair: R. Popescu, CH/RO
Co-chair: S. Beslija, BA
AIMS AND OBJECTIVES
This clinically oriented residential educational programme has been designed for dedicated physicians wishing to improve their skills in the management of cancer patients. The ESO Balkan Masterclass is dedicated to clinicians who are specifically and almost exclusively dedicated to medical oncology, radiation oncology and surgical oncology (breast and colon). The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-orientated training. The programme focuses on breast, GI cancers, lung and gynaecological cancers.
TEACHING FORMAT
Masteclass offers plenary lectures regarding the state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which conclude in taking-home messages. Furthermore, practical training will be offered in the frame of clinical case presentations prepared and presented by the faculty for an interactive discussion with participants. Participants will reside at the masterclass venue and participation is compulsory throughout the course.
The Masterclass will be entirely in English and fluency in English is necessary for admission.
THE MASTERCLASS IS:
• A 3-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of experts delivering lectures focusing on breast, GI, lung and gynaecological cancers.
General information
ORGANISING SECRETARIAT
Daniela Mengato - Roberta Ventura
European School of Oncology (ESO)
Via del Bollo, 4
20123 Milan, Italy
Tel: +39 02 8546 4523
Fax: +39 02 8546 4545
Email: balkans@eso.net
VENUE
Radisson Blu Resort & SPA
Dubrovnik Sun Gardens
Na Moru 1
Orašac Dubrovnik, Croatia
Tel: +385 20 361 500
Fax: +385 20 361 501
www.radissonblu.com/resort-dubrovnik
Faculty list
FACULTY
A. Anttila, Finnish Cancer Registry, Helsinki, FI
S. Beslija, Institute of Oncology, Clinical Center Sarajevo University, Sarajevo, BA
F. Cardoso, Champalimaud Cancer Center, Lisbon, PT
A. Celebic, Clinical Center of Montenegro, Podgorica, ME
A. Cervantes, Hospital Clinico Universitario, Valencia, ES
G. Cserni, Bacs Miskun County Teaching Hospital, Kecskemet, HU
T. Cufer, University Clinic of Respiratory and Allergic Diseases, Golnik, SI
R. Curca, Emergency County Hospital, Alba Iulia, RO
I. Daskalova, Bulgarian Cancer Institute, Sofia, BG
A. Eniu, Cancer Institute "I. Chiricuta", Cluj-Napoca, RO
V. Gregorc, San Raffaele Scientific Institute, Milano, IT
D. Jovanovic, Institute for Lung Disease, Clinical Center of Serbia, Belgrade, RS
M. Margaritoni, Dubrovnik General Hospital, Dubrovnik, HR
L. Patrlj, Clinical Hospital Dubrava, Zagreb, HR
R. Popescu, Hirslanden Klinik Aarau, CH/RO
D. Sebag-Montefiore, University of Leeds, Leeds Cancer Centre, UK
P. Stefanovski, Clinical Hospital, Bitola, MK
J.B. Vermorken, University Hospital Antwerp, Edegem, BE
D. Vrbanec, University Hospital Zagreb, HR
E. Vrdoljak, Clinical Hospital Split, Medical School Split, HR
J. Zgajnar, Institute of Oncology, Ljubljana, SI
Programme
11 May
18:30 | Welcome address |
19:00 | Multidisciplinarity in oncology R. Popescu, CH/RO - J. Zgajnar, SI |
| 20:00 | Dinner |
12 May
LUNG CANCER | |
| 8:30 - 10:10 Principles of thoracic oncology, early disease Chairs: T. Cufer, SI - D. Jovanovic, SR | |
8:30 | Epidemiology, pathology and molecular biology |
| 8:50 | Diagnostic procedures, staging and surgery of lung cancer D. Jovanovic, SR |
9:10 | Combined chemoradiotherapy |
| 9:40 | Adjuvant/neo adjuvant systemic therapy in NSCLC |
10:10 | Coffee break |
| 10:40 - 11:40 Advanced lung cancer Chairs: V. Gregorc, IT | |
10:40 | Individualized systemic therapy in NSCLC V. Gregorc, IT |
11:20 | Palliative and supportive care in lung cancer R. Curca, RO |
| 11:40 - 13:30 Case presentation and discussion (6 cases) Panel: T. Cufer, SI - D. Jovanovic, SR - E. Vrdoljak, HR - V. Gregorc, IT - R. Curca, RO | |
| 13:30 | Lunch break |
| 14:40 | Thyroid cancer A. Celebic, ME |
15:00 | Head and neck cancer - essential messages J.B. Vermorken, BE |
GYNAECOLOGICAL CANCERS | |
| 15:30 - 16:30 Ovarian cancer Chairs: J.B. Vermorken, BE - S. Beslija, BA | |
15:30 | First line treatment of ovarian cancer: surgery and adjuvant therapy J.B. Vermorken, BE |
16:00 | Controversies in recurrent ovarian cancer: role of CA125, timing, role of surgery and new treatment options of 2nd-line therapy S. Beslija, BA |
16:30 | Coffee break |
| 17:00 - 18:00 Cervical cancer Chairs: A. Anttila, FI - E. Vrdoljak, HR | |
17:00 | The European Commission programme for cervical cancer A. Anttila, FI |
17:30 | Advanced cervical cancer - what is the gold standard E. Vrdoljak, HR |
18:00 - 19:00 Case presentation and discussion with interactive voting | |
20:00 | Dinner speech: CECOG S. Beslija, BA |
13 May
GI CANCERS | |
8:30 - 10:50 Colorectal Cancer | |
8:30 | Epidemiology and pathology G. Cserni, HU |
8:45 | Imaging and local therapy of rectal cancer D. Sebag-Montefiore, UK |
9:30 | Adjuvant chemotherapy of colorectal cancer D. Vrbanec, HR |
9:50 | Multidisciplinary management of liver metastasis |
10:10 | Treatment of advanced disease P. Stefanovski, MK |
10:50 | Coffee break |
| 11:20 – 12:20 Case presentation and discussion with interactive voting (5 cases) “The best care with limited resources” Panel: A. Cervantes, ES - G. Cserni, HU - R. Popescu, CH/RO - D. Sebag-Montefiore, UK P. Stefanovski, MK - D. Vrbanec, HR | |
| 12:20 | Lunch break |
| 13:20 - 14:35 Gastric Cancer Chairs: R. Popescu, CH/RO - A. Cervantes, ES | |
13:20 | Epidemiology and pathology G. Cserni, HU |
13:35 | Treatment of operable gastric cancer R. Popescu, CH/RO – L. Patrlj, HR |
14:05 | Systemic treatment of advanced disease A. Cervantes, ES |
| 14:35 – 15:15 Case presentation and discussion with interactive voting (3-4 cases) Panel: A. Cervantes - G. Cserni, HU - R. Popescu, CH - L. Patrlj, HR D. Sebag-Montefiore, UK - P. Stefanovski, MK | |
| 16:00 | Social programme followed by dinner |
14 May
BREAST CANCER | |
| 9:00 - 10:10 Early breast cancer Chairs: E. Vrdoljak, HR - J. Zgajnar, SI | |
9:00 | Epidemiology and pathology G. Cserni, HU |
9:20 | Surgery (SLNB, management of non palpable lesions, specific problems of the Balkan region, oncoplastic surgery) J. Zgajnar, SI - M. Margaritoni, HR |
| 9:50 | Radiotherapy E. Vrdoljak, HR |
10:10 | Coffee break |
| 10:40 - 12:10 Adjuvant systemic therapy Chairs: F. Cardoso, PT - S. Beslija, BA | |
10:40 | Chemotherapy: when, why, prognostic factors, regiments, doses T. Cufer, SI |
11:10 | Hormone therapy: best options for pre and postmenopausal patients |
| 11:40 | Targeted therapy: trastuzumab and beyond S. Beslija, BA |
| 12:10 - 13:15 Case presentation and discussion with interactive voting (4-5 cases) Panel: S. Beslija, BA - F. Cardoso, PT - T. Cufer, SI - G. Cserni, HU - I. Daskalova, BG A. Eniu, RO - M. Margaritoni, HR - E. Vrdoljak, HR - J. Zgajnar, SI | |
| 13:15 | Lunch break |
| 14:45 - 16:30 Locally advanced / metastatic breast cancer Chairs: A. Eniu, RO - T. Cufer, SI | |
14:45 | How to optimize systemic therapy in LABC A. Eniu, RO |
15:05 | Locoregional therapy in LABC E. Vrdoljak, HR |
15:25 | Hormonal therapy options/management in metastatic breast cancer |
15:55 | Chemotherapy options/management issues in metastatic breast cancer F. Cardoso, PT |
16:30 | Coffee break |
| 17:00 - 18:00 Case presentation and discussion with interactive voting (4-5 cases) Panel: S. Beslija, BA - F. Cardoso, PT - T. Cufer, SI - I. Daskalova, BG - A. Eniu, RO M. Margaritoni, HR - E. Vrdoljak, HR - J. Zgajnar, SI | |
19:00 | Farewell dinner |
15 May
8:30 | Palliative Care |
9:30 | Discussion of open questions (present faculty) |
| 10:00 | Closure R. Popescu, CH/RO |